Cytek BioSciences (CTKB)

Company Profile

Cytek Biosciences, Inc. is a life sciences technology company engaged in the provision of cell analysis tools by leveraging novel technical approaches.

Company profile

Ticker

CTKB

Exchange

NASDAQ

Website

www.cytekdev.com/

CEO

Wenbin Jiang

Incorporated

Delaware

Location

California

Fiscal year end

Dec 31

Sector

Manufacturing > Analytical Laboratory Instrument Manufacturing

Industry (SIC)

Laboratory Analytical Instruments

Agilent • Waters • Bio-Rad Laboratories • Illumina • Avantor • Mettler-Toledo International • Bruker • Revvity • Seer • Prenetics Global Limited ...

SEC CIK

0001831915

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Cytek (Shanghai) BioSciences Co., Ltd. • Cytek (Wuxi) BioSciences Co. Ltd. • Cytek (Shanghai) Software Development Technology Co., Ltd. • Cytek Biosciences B.V. • Cytek Japan Corporation ...

IRS number

472547526

CTKB stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

8-K

Regulation FD Disclosure

14 Nov 23

Notice of late quarterly filing

13 Nov 23

8-K

Q3 2023 Earnings Call

9 Nov 23

8-K

Cytek Biosciences Reports Third Quarter 2023 Financial Results

8 Aug 23

Cytek Biosciences Reports Second Quarter 2023 Financial Results

8 Aug 23

8-K

Submission of Matters to a Vote of Security Holders

20 Jun 23

8-K/A

Financial Statements and Exhibits

9 May 23

Transcripts

View all

CTKB

Earnings call transcript

2023 Q3

7 Nov 23

CTKB

Earnings call transcript

2023 Q2

8 Aug 23

CTKB

Earnings call transcript

2023 Q1

9 May 23

CTKB

Earnings call transcript

2022 Q3

9 Nov 22

CTKB

Earnings call transcript

2022 Q2

11 Aug 22

CTKB

Earnings call transcript

2022 Q1

12 May 22

CTKB

Earnings call transcript

2021 Q4

24 Feb 22

CTKB

Earnings call transcript

2021 Q3

8 Nov 21

Latest ownership filings

View all

Paul Christopher Williams

Notice of proposed sale of securities

15 Nov 23

Wenbin Jiang

8 Nov 23

Financial summary

Financial statements Chart CTKB financial data

Quarter (USD)	Sep 23	Jun 23	Mar 23	Dec 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	163.63 mm	163.63 mm	163.63 mm	163.63 mm	163.63 mm	163.63 mm
Cash burn (monthly)	(no burn)	14.82 mm	2.14 mm	1.97 mm	1.41 mm	(no burn)
Cash used (since last report)	n/a	32.39 mm	4.68 mm	4.30 mm	3.09 mm	n/a
Cash remaining	n/a	131.24 mm	158.95 mm	159.33 mm	160.54 mm	n/a
Runway (months of cash)	n/a	8.9	74.3	81.0	113.6	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2023

CTKB institutional ownership history Ownership history

61.2% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	106	102	+3.9%
Opened positions	18	25	-28.0%
Closed positions	14	23	-39.1%
Increased positions	53	51	+3.9%
Reduced positions	22	17	+29.4%

13F shares	Current	Prev Q	Change
Total value	411.14 bn	640.88 bn	-35.8%
Total shares	82.95 mm	82.69 mm	+0.3%
Total puts	9.30 k	3.60 k	+158.3%
Total calls	32.10 k	67.10 k	-52.2%
Total put/call ratio	0.3	0.1	+440.0%

Largest owners	Shares	Value	Change
BLK Blackrock	16.77 mm	$92.57 bn	+10.9%
Brown Capital Management	13.56 mm	$74.85 bn	+26.4%
Vanguard	11.08 mm	$61.16 bn	+4.3%
Ra Capital Management	6.81 mm	$37.59 bn	-44.6%
Hillhouse Capital Advisors	6.66 mm	$36.75 bn	0.0%
3E Bioventures Capital	5.68 mm	$0.00	0.0%
STT State Street	3.78 mm	$20.85 bn	+10.9%
Geode Capital Management	2.35 mm	$13.00 bn	+14.2%
New York State Common Retirement Fund	2.35 mm	$12.96 mm	+42.5%
Wellington Management	1.45 mm	$7.98 bn	+7.4%

Largest transactions	Shares	Bought/sold	Change
Ra Capital Management	6.81 mm	-5.49 mm	-44.6%
Brown Capital Management	13.56 mm	+2.83 mm	+26.4%
BLK Blackrock	16.77 mm	+1.64 mm	+10.9%
MCQEF Macquarie	0.00	-1.25 mm	EXIT
New York State Common Retirement Fund	2.35 mm	+700.70 k	+42.5%
Dimensional Fund Advisors	910.74 k	+570.51 k	+167.7%
Vanguard	11.08 mm	+461.14 k	+4.3%
Miura Global Management	0.00	-380.59 k	EXIT
STT State Street	3.78 mm	+370.11 k	+10.9%
Renaissance Technologies	296.90 k	+296.90 k	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

CTKB insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
24 Nov 23	Patrick Jeanmonod	Common Stock	Sell	Dispose S	No	Yes	6.94	3,000	20.82 k	96,400
18 Nov 23	Valerie Barnett	Common Stock	Payment of exercise	Dispose F	No	No	5.98	1,434	8.58 k	31,943
18 Nov 23	Valerie Barnett	Common Stock	Option exercise	Acquire M	No	No	0	3,681	0.00	33,377
18 Nov 23	Valerie Barnett	Common Stock	Payment of exercise	Dispose F	No	No	5.98	786	4.70 k	29,696
18 Nov 23	Valerie Barnett	Common Stock	Option exercise	Acquire M	No	No	0	2,016	0.00	30,482
18 Nov 23	Valerie Barnett	RSU Common Stock	Option exercise	Dispose M	No	No	0	3,681	0.00	49,090
18 Nov 23	Valerie Barnett	RSU Common Stock	Option exercise	Dispose M	No	No	0	2,016	0.00	17,474
18 Nov 23	Wenbin Jiang	Common Stock	Payment of exercise	Dispose F	No	No	5.98	3,965	23.71 k	5,288,095
18 Nov 23	Wenbin Jiang	Common Stock	Option exercise	Acquire M	No	No	0	11,781	0.00	5,292,060
18 Nov 23	Wenbin Jiang	Common Stock	Payment of exercise	Dispose F	No	No	5.98	2,275	13.60 k	5,280,279